Naloxone as an antidote for angiotensin converting enzyme inhibitor poisoning: a case report
Can J Anaesth
.
2020 Oct;67(10):1442-1443.
doi: 10.1007/s12630-020-01680-x.
Epub 2020 Apr 27.
Authors
Vatsal Trivedi
1
,
Bryan A Glezerson
2
3
,
Dipayan Chaudhuri
4
,
Morgan Davidson
5
6
,
Ghislaine Douflé
7
5
8
Affiliations
1
Interdepartment Division of Critical Care Medicine, Toronto General Hospital, University of Toronto, Toronto, ON, Canada. vatsal.trivedi@uottawa.ca.
2
Department of Anesthesiology and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
3
Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
4
Department of Medicine, McMaster University, Hamilton, ON, Canada.
5
Medical-Surgical Intensive Care, University Health Network, Toronto, ON, Canada.
6
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
7
Interdepartment Division of Critical Care Medicine, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
8
Department of Anesthesia and Pain Management, Toronto, General Hospital, University Health Network, Toronto, ON, Canada.
PMID:
32342351
PMCID:
PMC7223556
DOI:
10.1007/s12630-020-01680-x
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Angiotensin-Converting Enzyme Inhibitors* / adverse effects
Antidotes*
Humans
Naloxone
Substances
Angiotensin-Converting Enzyme Inhibitors
Antidotes
Naloxone